References
- TakimotoCHWrightJArbuckSGClinical applications of the camptothecinsBiochimica et Biophysica Acta (BBA) – Gene Structure and Expression199814001–31071199748525
- MrossKRichlyHSchleucherNA phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumorsAnn Oncol20041581284129415277271
- HouseholderKTDipernaDMChungEPIntravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intra-cranial gliomaInt J Pharm2015479237438025562639
- YangYYeJMaPXuXXiaXLiuYFolate and CPP mediated specific delivery of camptothecin to tumor pH and reduction dual-sensitive micellesJ Control Release2017259e164e165
- FangSHouYLingLDimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapyColloids Surf B Biointerfaces201816623524429604567
- DramouPFizirMTalebAFolic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecinCarbohydr Polym201819711712730007596
- FröhlichEKueznikTSambergerCRobleggEWrightonCPieberTRSize-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymesToxicol Appl Pharmacol2010242332633219909766
- WilliamsJAHylandRJonesBCDrug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratiosDrug Metab Dispos200432111201120815304429
- KeshavaCMccanliesECWestonACYP3A4 polymorphisms – potential risk factors for breast and prostate cancer: a HuGE reviewAm J Epidemiol2004160982584115496535
- ZhaoZHuYHarmonTPentelPREhrichMZhangCHybrid nanoparticle-based nicotine nanovaccines: boosting the immunological efficacy by conjugation of potent carrier proteinsNanomedicine20181451655166529719216
- RagelleHDanhierFPréatVLangerRAndersonDGNanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field maturesExpert Opin Drug Deliv201714785186427730820
- ZhaoZHuYHoerleRA nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacyNanomedicine201713244345427520729
- ScownTMGoodheadRMJohnstonBDAssessment of cultured fish hepatocytes for studying cellular uptake and (eco)toxicity of nanoparticlesEnviron Chem2010713649
- LambJGHathawayLBMungerMARaucyJLFranklinMRNanosilver particle effects on drug metabolism in vitroDrug Metab Dispos201038122246225120861156
- FröhlichEKueznikTSambergerCRobleggEWrightonCPieberTRSize-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymesToxicol Appl Pharmacol2010242332633219909766
- NabeshiHYoshikawaTMatsuyamaKSystemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical applicationBiomaterials201132112713272421262533
- WilkesGMTargeted therapy: attacking cancer with molecular and immunological targeted agentsAsia Pac J Oncol Nurs20185213715529607374
- JungCFourier transform infrared spectroscopy as a tool to study structural properties of cytochromes P450 (CYPs)Anal Bioanal Chem200839261031105818581103
- ShaoJChenJLiTZhaoXSpectroscopic and molecular docking studies of the in vitro interaction between puerarin and cytochrome P450Molecules20141944760476924743933
- ZhongJSongLMengJBio–nano interaction of proteins adsorbed on single-walled carbon nanotubesCarbon2009474967973
- BaoHJinXLiLLvFLiuTOX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery abilityJ Mater Sci Mater Med20122381891190122569733
- GanipineniLPUcakarBJoudiouNMagnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastomaInt J Nanomedicine2018134509452130127603
- ZhaoZLouSHuYZhuJZhangCA nano-in-nano polymer-dendrimer nanoparticle-based nanosystem for controlled multidrug deliveryMol Pharm20171482697271028704056
- HouseholderKTDipernaDMChungEPIntravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intra-cranial gliomaInt J Pharm2015479237438025562639
- SchafrothNArpagausCJadhavUYMakneSDouroumisDNano and microparticle engineering of water insoluble drugs using a novel spray-drying processColloids Surf B Biointerfaces20129081522019455
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
- FröhlichEKueznikTSambergerCRobleggEWrightonCPieberTRSize-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymesToxicol Appl Pharmacol2010242332633219909766
- ZhangLYangMWangQ10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in miceJ Control Release2007119215316217400320
- MoritaTHorikiriYSuzukiTYoshinoHPreparation of gelatin microparticles by co-lyophilization with poly(ethylene glycol): characterization and application to entrapment into biodegradable microspheresInt J Pharm20012191–212713711337173
- RajanMKrishnanPPradeepkumarPMagneto-chemotherapy for cervical cancer treatment with camptothecin loaded Fe3O4 functionalized β-cyclodextrin nanovehicleRSC Adv20177734627146285
- KrishnanPRajanMKumariSEfficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drugSci Rep2017711096228887536
- BaoHZhangQXuHYanZEffects of nanoparticle size on anti-tumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studiesInt J Nanomedicine20161192994027022260
- KimJAÅbergCSalvatiADawsonKARole of cell cycle on the cellular uptake and dilution of nanoparticles in a cell populationNat Nanotechnol2012716268
- ChoECZhangQXiaYThe effect of sedimentation and diffusion on cellular uptake of gold nanoparticlesNat Nanotechnol20116638539121516092
- KimBHanGToleyBJKimCKRotelloVMForbesNSTuning payload delivery in tumour cylindroids using gold nanoparticlesNat Nanotechnol20105646547220383126
- CedervallTLynchILindmanSUnderstanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProc Natl Acad Sci U S A200710472050205517267609
- KumarAMaHZhangXGold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatmentBiomaterials20123341180118922056754
- CartieraMSJohnsonKMRajendranVCaplanMJSaltzmanWMThe uptake and intracellular fate of PLGA nanoparticles in epithelial cellsBiomaterials200930142790279819232712
- AshokaSSeetharamappaJKandagalPBShaikhSMTInvestigation of the interaction between trazodone hydrochloride and bovine serum albuminJ Lumin20061211179186
- ZhangFNiYA Comparison Study on the Interaction of Sunset Yellow and β-Carotene with Bovine Serum AlbuminActa Chimica Sinica2012701213791384
- ChannuBCKalpanaHNEregowdaGBDassCHoughtonPJThimmaiahKNInteraction of substituted phenoxazine chemosensitizers with bovine serum albuminJ Pharm Biomed Anal199921477578510701943
- YjHLiuYZbPSsQInteraction of cromolyn sodium with human serum albumin: a fluorescence quenching studyBioorgan Med Chem20051366096614
- CongdonRWMuthGWSplittgerberAGThe binding interaction of Coomassie blue with proteinsAnal Biochem199321324074137694523